Toni Choueiri

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Toni Choueiri
Jun 5, 2025, 15:32 | Insight
Neeraj Agarwal Highlighted ASCO 2025 Presentation by Rana McKay on ETCTN Trial in mCRPC
Neeraj Agarwal, Postdoctoral fellow at City of Hope, shared a post on X: "Stellar presentation…
May 31, 2025, 18:45 | Blog
Chalothorn “Sai” Wannaphut to Present IMG Research as Co-Author with Arya Roy at ASCO 2025 Oral Session
Chalothorn “Sai” Wannaphut, Internal Medicine Resident at the  John A. Burns School of Medicine, shared…
Apr 29, 2025, 11:13 | Blog
Posts Not to Miss from AACR 2025: Part 2
The AACR Annual Meeting is one of the biggest events in the world of cancer research—bringing together…
Apr 28, 2025, 15:06 | Blog
Posts Not to Miss from AACR 2025: Part 1
The AACR Annual Meeting is one of the biggest events in the world of cancer…
Mar 26, 2025, 06:10 | Blog
Sumanta K. Pal: Neoantigen generation in kidney cancer
Sumanta K. Pal, Vice Chair of Academic Affairs at City of Hope, shared on X…
Feb 19, 2025, 17:31 | Blog
Myriam Chalabi: Abstract submission now open for ESMO25
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek Netherlands…
Feb 13, 2025, 17:58 | Blog
Bernard A. Fox: We need to do more for every patient fighting cancer
Bernard A. Fox, Co-Founder, President, and CEO of UbiVac, shared on LinkedIn: "A friend of mine…
Feb 12, 2025, 06:20 | Science
Miguel Bronchud: Good news for the commonest clinical kidney cancer
Miguel Bronchud, Co-Founder & Advisory Board at Regenerative Medicine Solutions, shared an article on LinkedIn:…
Feb 2, 2025, 03:03 | Blog
Emre Yekedüz: Our study on merlin-loss RCC has been awarded Conquer Cancer "Merit Award"
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, posted on X: "Happy to share…
Jan 29, 2025, 07:35 | Blog
Petros Grivas: Inspired after interacting with so awesome colleagues at AUC3
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Dec 29, 2024, 10:44 | Science
Top 5 Prostate Cancer Trials of 2024 by Toni Choueiri
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute,…
Dec 29, 2024, 08:34 | Blog
Tian Zhang: Always enjoy seeing Toni Choueiri top 10 GU papers of the year
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center,…
Dec 27, 2024, 17:02 | Insight
Toni Choueiri: Top 10 GU Bladder/Kidney Cancer Trials for 2024
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Dec 21, 2024, 09:06 | Science
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute,…
Dec 20, 2024, 14:04 | Science
Elvina Almuradova: JAVELIN Renal 101 Phase 3 Trial Results by Toni Choueiri et al.
A recent paper by Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at…
Dec 17, 2024, 21:00 | Blog
Toni Choueiri: The 4th Transatlantic Exchange in Oncology between Gustave Roussy and Dana-Farber
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, posted…
Dec 15, 2024, 03:39 | Insight
Petros Grivas: Phenomenal talk by Sumanta K. Pal on RCC
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Dec 11, 2024, 17:33 | Blog
GU Cast Urology podcast on how to approach Metastatic Kidney Cancer
Sumanta K. Pal, Medical Oncologist at the City of Hope Comprehensive Cancer Center, shared a…
Dec 9, 2024, 19:14 | Insight
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
Toni Choueiri shared a post on X: "Efficacy of Treatments After Lenvatinib in Patients with…
Dec 7, 2024, 15:17 | Blog
Paolo Tarantino: Reflecting on debates in Napoli and Bridge2024
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, retweeted a post by Toni Choueiri,…
Dec 7, 2024, 01:42 | Blog
Toni Choueiri: Excited to share the results of FRACTION-RCC
Toni Choueiri, the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer…
Dec 1, 2024, 21:24 | Blog
Toni Choueiri: Amazing journey all the way from Ankara to Boston and Back
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Nov 29, 2024, 15:31 | Insight
Thanksgiving Day 2024: A Time for Gratitude and Reflection
Thanksgiving Day in 2024 fell on November 28th. Thanksgiving Day is a national holiday celebrated…
Nov 26, 2024, 18:23 | Blog
Emirates Oncology Society - Exploring Advances in Genitourinary Cancer at Best of ESMO Gulf 2024
Emirates Oncology Society shared on LinkedIn: "Exploring Advances in Genitourinary Cancer at Best of ESMO Gulf…
Nov 17, 2024, 09:56 | Blog
Toni Choueiri received the Lifetime Achievement Award at The King Hussein Cancer Foundation Annual Celebration
Toni Choueiri from Dana-Farber Cancer Institute Honored with Lifetime Achievement Award at The King Hussein…
Nov 17, 2024, 07:33 | Blog
Toni Choueiri: Honored by the King Hussein Cancer Foundation
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute,…
Nov 10, 2024, 10:44 | Insight
Highlights from IKCSNA24: 20 Posts Not to Miss
The 2024 International Kidney Cancer Symposium: North America (IKCSNA24) held from November 7-9, 2024, at…
Nov 9, 2024, 20:04 | Blog
Toni Choueiri on the Flexibility of Therapies Beyond PD-1 Inhibitors
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, shared…
Nov 9, 2024, 10:21 | Blog
Toni Choueiri: Our recent perspective on the next therapies in immuno-oncology trials
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, posted…
Nov 8, 2024, 18:55 | Insight
Regina Barragan-Carrillo: First and second - line treatments in metastatic renal cell carcinoma
Regina Barragan-Carrillo, Postdoctoral fellow at the Genitourinary Clinic at the Medical Oncology and Medical Therapeutics…
Nov 8, 2024, 13:58 | Blog
Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…
Nov 7, 2024, 15:54 | Blog
ESMO 2024 GU Highlights hosted by Wenxin (Vincent) Xu - Dana-Farber Lank Center for Genitourinary Oncology
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X: "Did you miss ESMO…
Nov 6, 2024, 12:05 | Blog
Karl Semaan: Landscape of subsequent therapies in perioperative immunotherapy trials
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, posted on X about recent…
Nov 4, 2024, 15:59 | Blog
Toni Choueiri: Vas Narasimhan on drug development, pre-clinical science, strategies and real world data
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, shared…
Nov 2, 2024, 20:15 | Blog
ArteraAI Multimodal Artificial Intelligence
Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, congrats team ArteralAI on LinkedIn:…
Oct 26, 2024, 12:57 | Societies
Highlights from the 36th EORTC-NCI-AACR Symposium 2024
The 36th EORTC-NCI-AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics was held at the…
Oct 23, 2024, 15:41 | Career
Matthew Vander Heiden is elected as a member of the National Academy of Medicine
Matthew Vander Heiden, Director of the Koch Institute for Integrative Cancer Research at MIT, was…
Oct 14, 2024, 15:14 | Drugs
Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC
Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…
Oct 13, 2024, 05:19 | Blog
Impressive progress in prostate adeno/NEPC driven in large part by Misha Beltran
Toni Choueiri shared a post on X: "What can Misha Beltran not do? Impressive progress in…
Oct 11, 2024, 14:37 | Insight
U.S. FDA approved nivolumab with platinum-doublet chemotherapy
Toni Choueiri shared a post on X: "JUST IN: US_FDA approved nivolumab with platinum-doublet chemotherapy…
Oct 9, 2024, 14:32 | Career
Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair
Toni Choueiri shared a post about Eli Van Allen. Read his post on X below:…
Oct 7, 2024, 18:24 | Blog
Toni Choueiri: The mood for the 2024 The Jimmy Fund walk
Toni Choueiri shared a post on LinkedIn: "The mood in Hopkinton who is hosting us…
Oct 4, 2024, 08:17 | Blog
Zainab Shinkafi-Bagudu: There is power in numbers
Zainab Shinkafi-Bagudu shared a post on LinkedIn by Creation.co adding: "The power and reach of…
Oct 1, 2024, 04:54 | Positive
Empowering Women in Oncology: LEAD 2024 Recognized Rana McKay and Nazli Dizman
Dr. Rana McKay and Dr. Nazli Dizman were honored at the LEAD 2024 The Leadership, Empowerment,…
Sep 29, 2024, 14:56 | Insight
Highlights from The LEAD Conference 2024
The Leadership, Empowerment, and Development (LEAD) Conference 2024 took place from September 27th- 28th at…
Sep 20, 2024, 09:38 | Blog
Toni Choueiri: Surrogate markers of survival in kidney cancer
Toni Choueiri posted on X: "Work from the IMDC database looking at surrogate markers of…
Sep 19, 2024, 14:05 | Blog
Yuksel Urun: The conference rooms are no longer enough for GU sessions at ESMO 24
Petros Grivas shared a post by Yuksel Urun on X: "Thrilled to co-chair GU session…
Sep 19, 2024, 11:50 | Insight
Toni Choueiri: The tradition of ASCO ESMO soccer tournament
Toni Choueiri shared a post on X: “Very prepared Turkish, Swiss and Dutch - they all…
Sep 19, 2024, 08:59 | Insight
Fantastic talk by Toni Choueiri at ESMO2024 on Ti-Nivo2 trial
Petros Grivas shared a post by Yüksel Ürün on X, adding: "Fantastic talk by brilliant Toni Choueiri…
Sep 19, 2024, 04:32 | Societies
Best of ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 18, 2024, 14:14 | Blog
Petros Grivas: Ipilimumab/nivolumab vs standard care in non-clear cell renal cell cancer by Andrea Apolo
Petros Grivas shared a post by Andrea Apolo on X: "Agree with Andrea Apolo excellent…
Sep 18, 2024, 11:25 | Insight
Toni Choueiri: PEACE-3 phase 3 trials first results at ESMO24
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X by…
Sep 18, 2024, 06:20 | Blog
Toni Choueiri: Results from TiNivo2 are out at ESMO24 and The Lancet
Toni Choueiri shared a post on X: "Results from TiNivo2 are out both ESMO24 and…
Sep 17, 2024, 15:11 | Blog
Toni Choueiri: New standard of care for high-risk locally advanced cervical cancer
Toni Choueiri shared a post on X: ''New standard of care for high-risk locally advanced…
Sep 17, 2024, 15:03 | Societies
Are you presenting a Poster at ESMO24?
  The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 17, 2024, 15:03 | Blog
Vivek Subbiah: Now that we have landed in the moon off to Mars
Vivek Subbiah shared a post on X: ''To the moon! Huge congratulations to Toni Choueiri…
Sep 17, 2024, 10:19 | Insight
Renee Maria Saliby: Is ICI-rechallenge the right thing to do in renal cell carcinoma?
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X:…
Sep 17, 2024, 10:06 | Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 15, 2024, 16:26 | Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 15:33 | Insight
Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma
Toni Choueiri shared a post on X about a recent paper by Brian Shuch et…
Sep 14, 2024, 13:44 | Societies
Neeraj Agarwal's highlights from ESMO24
The ESMO Congress 2024 (ESMO24) is one of the most globally influential platforms in oncology,…
Sep 12, 2024, 09:40 | Blog
What five doctors are excited about in Kidney Cancer research - KidneyCAN
KidneyCAN shared a post on X: "Out today in TIME - a review of recent advances…
Sep 11, 2024, 17:41 | Blog
Karen Knudsen: Thrilled to visit ⁦Dana-Farber Cancer Institute⁩ to deliver the Christopher Sweeney Lecture in prostate cancer
Karen Knudsen shared a post on LinkedIn: "Thrilled to visit ⁦Dana-Farber Cancer Institute⁩ to deliver the…
Sep 10, 2024, 14:54 | Blog
Tom Powles: Belzutifan for clear cell renal cancer
Tom Powles shared a post on X: “Belzutifan significantly outperformed Everolimus in heavily pretreated clear…
Sep 10, 2024, 14:51 | Blog
Toni Choueiri: An elegant paper about renal cell cancer tumor metabolism by DeBerardinis Lab
Toni Choueiri shared a post by Divya Bezwada, Postdoctoral Fellow at Scripps Research, on X, adding:…
Sep 7, 2024, 11:44 | Insight
Toni Choueiri: Celebrating Matt Freedman, the new David Goldstein Chair at Dana-Farber Cancer Institute
Toni Choueiri shared on X: “A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman,…
Sep 1, 2024, 04:23 | Insight
Joaquim Bellmunt: Proud of learning from negative trials
Toni Choueiri shared a post by Joaquim Bellmunt, Director Bladder Cancer Center at Dana-Farber Cancer…
Aug 29, 2024, 02:57 | Blog
Newly released ASCO principles for responsible use of AI in oncology
Toni Choueiri shared a post by Julie Gralow, adding: "Very important task force led by…
Aug 27, 2024, 19:10 | Blog
Petros Grivas: Looking forward to a fantastic ESMO24
Petros Grivas shared a post on X by ESMO, adding: "Looking forward to a fantastic…
Aug 26, 2024, 08:35 | Insight
Highlights from The California Cancer Consortium Conference 2024 by Sumanta K. Pal
The California Cancer Consortium Conference is an annual conference that brings together leading oncology experts,…
Aug 25, 2024, 14:05 | Blog
Petros Grivas: Can’t wait for amazing Uromigos meeting!
Petros Grivas shared a post on X by Uromigos adding: "Can’t wait for amazing Uromigos…
Aug 25, 2024, 13:02 | Insight
Toni Choueiri: Results from LITESPARK-005 are out
Toni Choueiri shared a post on X about a recent paper titled "Belzutifan versus Everolimus…
Aug 24, 2024, 06:53 | Insight
Srinivas Viswanathan: A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
Recently, an article by Srinivas Viswanathan et al. titled "A genetic basis for sex differences in…
Aug 20, 2024, 10:02 | Blog
Toni Choueiri: Announcement for folks going to ESMO24
Toni Choueiri shared a post on X by Daniel Castellano, Medical Oncologist at University Hospital…
Aug 19, 2024, 12:16 | Insight
Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?
Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…
Aug 17, 2024, 08:50 | Insight
Karl Semaan: Our study on first-line systemic therapy after adjuvant immunotherapy in RCC
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X…
Aug 17, 2024, 08:18 | Societies
Highlights from KCancer by the Jimmy Fund
The Jimmy Fund, founded in Boston in 1948, consists of community-driven fundraising events and programs…
Aug 16, 2024, 14:16 | Insight
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…
Aug 8, 2024, 02:15 | Blog
Toni Choueiri: The KCRS24 abstracts are now published in The Oncologist!
Toni Choueiri shared a post on X: “The KCRS24 abstracts are now published in The…
Aug 7, 2024, 16:50 | Blog
The recipients of the 2024 ESMO Society Awards
The 2024 ESMO Society Awards have been announced on 6th August by ESMO. ESMO recently…
Aug 7, 2024, 01:22 | Insight
8 years of follow-up in the CheckMate 214 trial
Yüksel Ürün shared a paper by Nizar M. Tannir et al. on X: "Nivolumab +…
Aug 4, 2024, 12:18 | Insight
Toni Choueiri: Day 1 of Pan-Mass Challenge (85 miles) done
Toni Choueiri shared a post on X: “Day 1 of Pan-Mass Challenge (85 miles) done:…
Aug 3, 2024, 00:00 | Positive
Chong-xian Pan received VA grant to establish GU precision Oncology network
Chong-xian Pan, Associate Professor Of Medicine at Brigham and Women's Hospital, shared a post on…
Aug 2, 2024, 14:28 | Blog
Chuck Stravin: Proof of how a simple Doctor/Patient relationship turns into a 'true brotherhood'
Chuck Stravin made the following post on X: "Another birthday. Thanks Toni Choueiri & Dana-Farber…
Aug 1, 2024, 06:56 | Blog
Radiologic assessment before first line therapy for mccRCC
Cancer Network shared a post on X: ''Radiological tumor burden, if shown to have a…
Jul 31, 2024, 00:54 | Blog
Toni Choueiri: One of the coolest things I have seen recently
Toni Choueiri shared a post by William Gibson, Medical Oncologist at Dana-Farber Cancer Institute, on X,…
Jul 29, 2024, 11:50 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Toni Choueiri
We are pleased to highlight Dr. Toni Choueiri, a leading expert in genitourinary oncology, as…
Jul 25, 2024, 13:04 | Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 22, 2024, 16:58 | Blog
Toni Choueiri: Positive topline results for darolutamide in men with mHSPC
Toni Choueiri, shared a post on X: “Positive topline results for darolutamide from Phase III…
Jul 22, 2024, 13:38 | Blog
Toni Choueiri: Excited for PMC2024 where over 7000 riders are focused on 1 mission
Toni Choueiri posted on X: "Last training ride before Pan-Mass Challenge ride on Team More…
Jul 20, 2024, 10:51 | Blog
Toni Choueiri: TiNivo2 results are out
Toni Choueiri shared a post on X: ''TiNivo2 results are out - adding PD1 inhibitor…
Jul 15, 2024, 11:30 | Blog
Neeraj Agarwal: Excellent talk by Michelle Hirsch on the pathology diagnosis of RCC variants
Neeraj Agarwal shared on X: "Surgical Pathology Toolbox and Technological Advances to Solve Kidney Cancer…
Jul 14, 2024, 05:55 | Blog
RNA vaccines generate tumour specific immune responses with limited toxicity
Thomas Powles posted on X: "Personalised cancer vaccine trials have started in the adjuvant setting…
Jul 13, 2024, 20:46 | Blog
Yüksel Ürün: Outstanding presentation at KCRS24 Rohit Mehra
Yüksel Ürün shared on X: "Outstanding presentation at KCRS 24 Rohit Mehra Role of Pathologist…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jul 12, 2024, 13:32 | Societies
Insights from KCRS24 by Neeraj Agarwal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in…
Jul 12, 2024, 12:43 | Blog
KidneyCAN - Insights from Toni Choueiri on Belzutifan monotherapy at KCRS24
KidneyCAN shared on LinkedIn: "KCRS24 Oral Abstract: Exciting insights from Toni Choueiri on the safety profile…
All: 208 Posts: 1 - 100
Special Coverage